Advancing molecular residual disease detection in cervical cancer through next‐generation sequencing of circulating human papillomavirus DNA

Documenti analoghi

• Ultrasensitive next‐generation sequencing–based detection of circulating human papillomavirus DNA for cervical cancer recurrence monitoring
  di: Sara Bønløkke, et al.
  Pubblicazione: (2026)
• Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes in HPV‐associated oropharyngeal cancer
  di: Sachin R. Jhawar, et al.
  Pubblicazione: (2024)
• Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung cancer
  di: Aaron C. Tan, et al.
  Pubblicazione: (2024)
• Utility of circulating tumor DNA to detect minimal residual disease in colorectal cancer: A systematic review and network meta‐analysis
  di: Tung Hoang, et al.
  Pubblicazione: (2025)
• Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women
  di: Mònica Ortega Llobet, et al.
  Pubblicazione: (2025)